Global Variome shared LOVD
CYP2C8 (cytochrome P450, family 2, subfamily C, pol...)
LOVD v.3.0 Build 30b [
Current LOVD status
]
Register as submitter
|
Log in
Curator:
Global Variome, with Curator vacancy
View all genes
View CYP2C8 gene homepage
View graphs about the CYP2C8 gene database
Create a new gene entry
View all transcripts
View all transcripts of gene CYP2C8
Create a new transcript information entry
View all variants
View all variants affecting transcripts
View unique variants in gene CYP2C8
View all variants in gene CYP2C8
Full data view for gene CYP2C8
Create a new data submission
View active genomic custom columns
Enable more genomic custom columns
View all individuals
View all individuals with variants in gene CYP2C8
Create a new data submission
View active custom columns
Enable more custom columns
View all diseases
View all diseases associated with gene CYP2C8
Create a new disease information entry
View available phenotype columns
View all screenings
View all screenings for gene CYP2C8
Create a new data submission
View active custom columns
Enable more custom columns
Submit new data
Unique variants in the CYP2C8 gene
CYP2C8 reference haplotypes
.
Functional analysis variants
The variants shown are described using the NM_000770.3 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Reported
: The number of times this variant has been reported in the database.
Exon
: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA)
: description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change
: description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Haplotype
: haplotype on which variant was found
Classification method
: The method used for the clinical classification of this variant.
All options:
ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other
Clinical classification
: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
conflicting
association
NA
DNA change (genomic) (hg19)
: HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38)
: HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as
: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN
: description of the variant according to ISCN nomenclature
DB-ID
: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks
: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference
: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID
: ID of variant in ClinVar database
dbSNP ID
: the dbSNP ID
Origin
: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable
Segregation
: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable
Frequency
: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site
: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP
: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Methylation
: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)
How to query this table
All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator
Column type
Example
Matches
Text
Arg
all entries containing 'Arg'
space
Text
Arg Ser
all entries containing 'Arg' and 'Ser'
|
Text
Arg|Ser
all entries containing 'Arg' or 'Ser'
!
Text
!fs
all entries not containing 'fs'
^
Text
^p.(Arg
all entries beginning with 'p.(Arg'
$
Text
Ser)$
all entries ending with 'Ser)'
=""
Text
=""
all entries with this field empty
=""
Text
="p.0"
all entries exactly matching 'p.0'
!=""
Text
!=""
all entries with this field not empty
!=""
Text
!="p.0"
all entries not exactly matching 'p.0?'
combination
Text
*|Ter !fs
all entries containing '*' or 'Ter' but not containing 'fs'
Date
2020
all entries matching the year 2020
|
Date
2020-03|2020-04
all entries matching March or April, 2020
!
Date
!2020-03
all entries not matching March, 2020
<
Date
<2020
all entries before the year 2020
<=
Date
<=2020-06
all entries in or before June, 2020
>
Date
>2020-06
all entries after June, 2020
>=
Date
>=2020-06-15
all entries on or after June 15th, 2020
combination
Date
2019|2020 <2020-03
all entries in 2019 or 2020, and before March, 2020
Numeric
23
all entries exactly matching 23
|
Numeric
23|24
all entries exactly matching 23 or 24
!
Numeric
!23
all entries not exactly matching 23
<
Numeric
<23
all entries lower than 23
<=
Numeric
<=23
all entries lower than, or equal to, 23
>
Numeric
>23
all entries higher than 23
>=
Numeric
>=23
all entries higher than, or equal to, 23
combination
Numeric
>=20 <30 !23
all entries with values from 20 to 29, but not equal to 23
Some more advanced examples:
Example
Matches
Asian
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian
all entries containing 'Asian' but not containing 'Caucasian'
Asian|African !Caucasian
all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"
all entries containing 'South Asian', but not containing 'South East Asian'
To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
43 entries on 1 page. Showing entries 1 - 43.
10 per page
25 per page
50 per page
100 per page
Legend
How to query
Effect
Reported
Exon
DNA change (cDNA)
RNA change
Protein
Haplotype
Classification method
Clinical classification
DNA change (genomic) (hg19)
DNA change (hg38)
Published as
ISCN
DB-ID
Variant remarks
Reference
ClinVar ID
dbSNP ID
Origin
Segregation
Frequency
Re-site
VIP
Methylation
Owner
-?/.
1
_1
c.-2898T>C
r.(=)
p.(=)
-
-
likely benign
g.96832057A>G
g.95072300A>G
-2898T>C
-
CYP2C8_001026
14 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
55/100 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
_1
c.-2599delA
r.(=)
p.(=)
-
-
likely benign
g.96831766del
g.95072009del
-2599delA
-
CYP2C8_001025
14 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
55/100 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
_1
c.-2230G>A
r.(=)
p.(=)
-
-
likely benign
g.96831389C>T
g.95071632C>T
-2230G>A
-
CYP2C8_001024
15 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
57/100 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
_1
c.-2028A>G
r.(=)
p.(=)
-
-
likely benign
g.96831187T>C
g.95071430T>C
-2028G>A
-
CYP2C8_001023
no homozygotes
PubMed: Yeo 2011
-
-
Germline
-
7/100 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
_1
c.-411C>T
r.(=)
p.(=)
-
-
likely benign
g.96829570G>A
g.95069813G>A
-411C>T
-
CYP2C8_001027
15 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
57/100 chromosomes
-
-
-
Johan den Dunnen
-?/-?, -?/.
3
_1
c.-370T>G
r.(=), r.=
p.(=), p.=
CYP2C8*1C
-
likely benign
g.96829529A>C
g.95069772A>C
-370T>G, T-370G
-
CYP2C8_001002
6 homozygotes, liver microsome analysis showed no significant expression differences,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Bahadur 2002
,
1 more item
-
rs17110453
Germline
-
13/214 chromosomes, 35/100 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
-/., -?/-?, -?/.
3
_1
c.-271C>A
r.(=), r.=
p.(=), p.=
CYP2C8*1B
-
benign, likely benign
g.96829430G>T
g.95069673G>T
-271C>A, C-271A
-
CYP2C8_001001
liver microsome analysis showed no expression differences, no homozygotes,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Bahadur 2002
,
1 more item
-
rs7909236
Germline
-
13/214 chromosomes, 8/100 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
-/-
1
1_9
c.=
r.(?)
p.=
CYP2C8*1A
-
benign
g.96796885_96829159=
-
-
-
CYP2C8_000001
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Sarah C Sim
-?/.
1
1i
c.169-121C>T
r.(=)
p.(=)
-
-
likely benign
g.96827569G>A
g.95067812G>A
-
-
CYP2C8_001013
-
PubMed: Soyama 2002
-
-
Germline
-
1/108 chromosomes
-
-
-
Johan den Dunnen
-?/., ?/.
2
1i
c.169-37C>T
r.(?)
p.=
CYP2C8*2, CYP2C8*3
-
likely benign, VUS
g.96827485G>A
g.95067728G>A
1675C>T
-
CYP2C8_001003
decreased in vitro enzyme activity; reference haplotype CYP2C8*2,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
rs11572073
Germline
-
-
-
-
-
Sarah C Sim
-?/.
1
2i
c.332-64A>G
r.(?)
p.(=)
-
-
likely benign
g.96827178T>C
g.95067421T>C
1982A>G
-
CYP2C8_001020
11 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
51/100 chromosomes
-
-
-
Johan den Dunnen
-?/., ?/.
2
2i
c.332-36G>A
r.(?)
p.=
CYP2C8*2, CYP2C8*3
-
likely benign, VUS
g.96827150C>T
g.95067393C>T
2010G>A
-
CYP2C8_001004
decreased in vitro enzyme activity; reference haplotype CYP2C8*2,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
rs11572076
Germline
-
-
-
-
-
Sarah C Sim
-?/.
2
2i
c.332-6dup
r.(=), r.(?)
p.(=), p.=
CYP2C8*2
-
likely benign
g.96827126dup
g.95067369dup
2040_2041insT, 2041insT
-
CYP2C8_001005
decreased in vitro enzyme activity; reference haplotype CYP2C8*2, no homozygotes
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Yeo 2011
-
rs11572078
Germline
-
26/100 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
+/., ?/.
6
3
c.416G>A
r.(?)
p.(Arg139Lys), p.Arg139Lys
CYP2C8*3
-
NA, pathogenic, VUS
g.96827030C>T
g.95067273C>T
2130G>A
-
CYP2C8_000003
cDNA expression cloning shows defective paclitaxel and arachidonic acid metabolism,
3 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Dai 2001
,
1 more item
-
rs11572080
Germline, In vitro (cloned)
-
3/164 chromosomes, 44/340 chromosomes
BspQI+;SapI+;BseRI-
-
-
Johan den Dunnen
,
Sarah C Sim
+?/.
1
3
c.419G>A
r.(?)
p.(Arg139Lys)
CYP2C8*3
-
likely pathogenic
g.96827027C>T
g.95067270C>T
G416A
-
CYP2C8_001009
liver microsome analysis showed showed significantly lower paclitaxel 6alpha-hydroxylase activity
PubMed: Bahadur 2002
-
-
Germline
-
16/214 chromosomes
-
-
-
Johan den Dunnen
+/+, +/.
3
3
c.475del
r.(?)
p.(Thr159Profs*19), p.Thr159Profs*19
CYP2C8*5
-
pathogenic
g.96826975del
g.95067218del
2189delA (159fs)
-
CYP2C8_000005
no in vivo enzyme activity; reference haplotype CYP2C8*5
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Nakajima 2006
,
1 more item
-
rs72558196
Germline
-
1/108 chromosomes, 1/470 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
-?/.
1
3
c.480G>A
r.(?)
p.(Lys160=)
-
-
likely benign
g.96826966C>T
g.95067209C>T
K160K
-
CYP2C8_001012
-
PubMed: Dai 2001
-
-
Germline
-
-
-
-
-
Johan den Dunnen
-?/.
1
3i
c.482-97del
r.(=)
p.(=)
-
-
likely benign
g.96824815del
g.95065058del
IVS3-97delT
-
CYP2C8_001014
-
PubMed: Soyama 2002
-
-
Germline
-
1/108 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
3i
c.482-21T>A
r.(?)
p.(=)
-
-
likely benign
g.96824738A>T
g.95064981A>T
4424T>A
-
CYP2C8_001021
1 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
6/100 chromosomes
-
-
-
Johan den Dunnen
-/-, -?/.
4
4
c.511G>A
r.(?)
p.(Gly171Ser), p.Gly171Ser
CYP2C8*6
-
benign, likely benign, NA
g.96824688C>T
g.95064931C>T
4472G>A, 4472G>A (G171S)
-
CYP2C8_000006
no homozygotes, unchanged in vitro enzyme activity; reference haplotype CYP2C8*6,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hichiya 2005
,
1 more item
-
rs142886225
Germline, In vitro (cloned)
-
1/100 chromosomes, 1/201 individuals
-
-
-
Johan den Dunnen
,
Sarah C Sim
+/+, +/.
4
4
c.556C>G
r.(?)
p.(Arg186Gly), p.Arg186Gly
CYP2C8*8
-
NA, pathogenic
g.96824643G>C
g.95064886G>C
4517C>G
-
CYP2C8_000008
decreased in vitro enzyme activity; reference haplotype CYP2C8*8,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hichiya 2005
,
1 more item
-
rs72558195
Germline, In vitro (cloned)
-
1/201 individuals, 1/470 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
+/+, +/.
4
4
c.556C>T
r.(?)
p.(Arg186*), p.Arg186*
CYP2C8*7
-
NA, pathogenic
g.96824643G>A
g.95064886G>A
4517C>T
-
CYP2C8_000007
no in vitro enzyme activity; reference haplotype CYP2C8*7,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hichiya 2005
,
1 more item
-
rs72558195
Germline, In vitro (cloned)
-
1/201 individuals, 1/470 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
-/-, -?/.
3
5
c.669T>G
r.(?)
p.(Ile223Met), p.Ile223Met
CYP2C8*13
-
benign, likely benign, NA
g.96818242A>C
g.95058485A>C
10918T>G
-
CYP2C8_000013
cDNA yeast expression cloning shows normal expression, normal affinity toward paclitaxel,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hanioka 2010
,
1 more item
-
-
Germline, In vitro (cloned)
-, ?
1/470 chromosomes
CviAII+;FatI+;NlaIII+
-
-
Johan den Dunnen
,
Sarah C Sim
+/+, +/., ?/.
3
5
c.712G>C
r.(?)
p.(Ala238Pro), p.Ala238Pro
CYP2C8*14
-
NA, pathogenic
g.96818199C>G
g.95058442C>G
10961G>C
-
CYP2C8_000014
cDNA yeast expression cloning shows reduced expression, decreased affinity toward paclitaxel,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hanioka 2010
,
1 more item
-
rs188934928
Germline, In vitro (cloned)
-
1/470 chromosomes
MnlI+
-
-
Johan den Dunnen
,
Sarah C Sim
-/-, -?/.
3
5
c.740A>G
r.(?)
p.(Lys247Arg), p.Lys247Arg
CYP2C8*9
-
benign, likely benign, NA
g.96818171T>C
g.95058414T>C
10989A>G
-
CYP2C8_000009
unchanged in vitro enzyme activity; reference haplotype CYP2C8*9,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hichiya 2005
-
-
Germline, In vitro (cloned)
-
1/201 individuals
-
-
-
Johan den Dunnen
,
Sarah C Sim
+/+, +/., +?/.
4
5
c.792C>G
r.(?)
p.(Ile264Met), p.Ile264Met
CYP2C8*4
-
likely pathogenic, NA, pathogenic
g.96818119G>C
g.95058362G>C
11041C>G, C792G
-
CYP2C8_000004
decreased in vitro enzyme activity; reference haplotype CYP2C8*4,
3 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Bahadur 2002
,
2 more items
-
rs1058930
Germline, In vitro (cloned)
-
8/200 chromosomes
BspDI-;ClaI-;TaqI-
-
-
Johan den Dunnen
,
Sarah C Sim
+/+, +/., +?/., -/., ?/.
7
5
c.805A>T
r.(?)
p.(Ile269Phe), p.Ile269Phe
CYP2C8*2
-
benign, NA, pathogenic, VUS
g.96818106T>A
g.95058349T>A
11054A>T, A805T
-
CYP2C8_000002
3 homozygous;
Clinindb (India)
, 68 heterozygous;
Clinindb (India)
, not in 170 European individuals,
3 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Bahadur 2002
,
3 more items
-
rs11572103
Germline, In vitro (cloned)
-
1/232 chromosomes, 29/164 chromosomes, 3/2794 individuals, 68/2794 individuals
-
-
-
Johan den Dunnen
,
Sarah C Sim
,
Mohammed Faruq
+/+, +/.
4
6
c.820G>T
r.(?)
p.(Glu274*), p.Glu274*
CYP2C8*11, CYP2C8*1;*11
-
pathogenic
g.96805708C>A
g.95045951C>A
23452G>T
-
CYP2C8_000011
higher plasma concentrations of rosiglitazone after single dose, reduced oral clearance,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Yeo 2011
-
rs78637571
Germline
-, ?
1/348 individuals, 2/100 individuals, 3/447 individuals
-
-
-
Johan den Dunnen
,
Sarah C Sim
-?/.
1
7
c.1059C>T
r.(?)
p.(His353=)
-
-
likely benign
g.96802737G>A
g.95042980G>A
H353H
-
CYP2C8_001011
-
PubMed: Dai 2001
-
-
Germline
-
-
-
-
-
Johan den Dunnen
-/-, -?/.
3
7
c.1149G>T
r.(?), r.spl?
p.(Lys383Asn), p.Lys383Asn
CYP2C8*10
-
benign, likely benign, NA
g.96802647C>A
g.95042890C>A
26513G>T
-
CYP2C8_000010
unchanged in vitro enzyme activity; reference haplotype CYP2C8*10,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Hichiya 2005
-
-
Germline, In vitro (cloned)
-
1/201 individuals
-
-
-
Johan den Dunnen
,
Sarah C Sim
-?/., ?/.
3
7i
c.1149+49T>A
r.(?)
p.(=), p.=
CYP2C8*2, CYP2C8*3
-
likely benign, VUS
g.96802598A>T
g.95042841A>T
26562T>A
-
CYP2C8_001006
11 homozygotes, decreased in vitro enzyme activity; reference haplotype CYP2C8*2,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Yeo 2011
-
rs2275620
Germline
-
51/100 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
-?/.
1
7i
c.1149+71C>T
r.(=)
p.(=)
-
-
likely benign
g.96802576G>A
g.95042819G>A
IVS7+71C>T
-
CYP2C8_001015
-
PubMed: Soyama 2002
-
-
Germline
-
3/108 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
-
c.1150G>A
r.(?)
p.(Gly384Ser)
-
-
likely benign
g.96798795C>T
-
CYP2C8(NM_001198855.1):c.940G>A (p.G314S)
-
CYP2C8_001029
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Rotterdam
?/.
1
8
c.1169T>C
r.(?)
p.(Leu390Ser)
-
-
VUS
g.96798776A>G
g.95039019A>G
T1169C
-
CYP2C8_001010
-
PubMed: Bahadur 2002
-
-
Germline
-
1/232 chromosomes
-
-
-
Johan den Dunnen
+/., +?/., ?/.
10
8, 9
c.1196A>G
r.(?)
p.(Lys399Arg), p.Lys399Arg
CYP2C8*3
-
likely pathogenic, NA, pathogenic, VUS
g.96798749T>C
g.95038992T>C
30411A>G, A1196G
-
CYP2C8_001007
cDNA expression cloning shows defective paclitaxel and arachidonic acid metabolism,
7 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Bahadur 2002
,
4 more items
-
rs10509681
Germline, In vitro (cloned)
-
16/214 chromosomes, 200/2793 individuals, 3/164 chromosomes, 4/2793 individuals, 44/340 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
,
Mohammed Faruq
?/.
1
-
c.1198G>T
r.(?)
p.(Glu400Ter)
-
-
VUS
g.96798747C>A
g.95038990C>A
CYP2C8(NM_001198855.1):c.988G>T (p.E330*)
-
CYP2C8_001028
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Rotterdam
+/.
3
8
c.1210C>G
r.(?)
p.(Pro404Ala), p.Pro404Ala
-
-
NA, pathogenic
g.96798735G>C
g.95038978G>C
-
-
CYP2C8_001022
2 more items
PubMed: Jian 2011
,
PubMed: Soyama 2001
-
-
Germline, In vitro (cloned)
-
1/146 chromosomes
-
-
-
Johan den Dunnen
-?/.
2
8
c.1230C>T
r.(?)
p.(Gly410=)
-
-
likely benign
g.96798715G>A
g.95038958G>A
30445C>T (G400G)
-
CYP2C8_001019
no homozygotes
PubMed: Nakajima 2006
,
PubMed: Yeo 2011
-
-
Germline
-
2/100 chromosomes, 9/470 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
8i
c.1291+106G>A
r.(?)
p.(=)
-
-
likely benign
g.96798548C>T
g.95038791C>T
30612G>A
-
CYP2C8_001018
8 homozygotes
PubMed: Yeo 2011
-
-
Germline
-
44/100 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
8i
c.1291+130T>C
r.(?)
p.(=)
-
-
likely benign
g.96798524A>G
g.95038767A>G
30636T>C
-
CYP2C8_001017
no homozygotes
PubMed: Yeo 2011
-
-
Germline
-
1/100 chromosomes
-
-
-
Johan den Dunnen
-?/.
1
8i
c.1292-204A>G
r.(=)
p.(=)
-
-
likely benign
g.96797270T>C
g.95037513T>C
IVS8-204A>G
-
CYP2C8_001016
-
PubMed: Soyama 2002
-
-
Germline
-
4/108 chromosomes
-
-
-
Johan den Dunnen
?/.
2
9
c.1382_1384del
r.(?)
p.(Val461del), p.Val461del
CYP2C8*12
-
VUS
g.96796976_96796978del
g.95037219_95037221del
32184_32186delTTG (461delV)
-
CYP2C8_000012
reference haplotype CYP2C8*12
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Saito 2007
-
rs3832694
Germline
-
1/347 individuals
Hpy188I+
-
-
Johan den Dunnen
,
Sarah C Sim
-?/., ?/.
3
9
c.*24C>T
r.(?)
p.(=), p.=
CYP2C8*2, CYP2C8*3
-
likely benign, VUS
g.96796861G>A
g.95037104G>A
32299C<T, 32299C>T
-
CYP2C8_001008
8 homozygotes, decreased in vitro enzyme activity; reference haplotype CYP2C8*2,
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Yeo 2011
-
rs1058932
Germline
-
43/100 chromosomes
-
-
-
Johan den Dunnen
,
Sarah C Sim
10 per page
25 per page
50 per page
100 per page
Legend
How to query
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our
APIs
to retrieve data.
Powered by
LOVD v.3.0
Build 30b
LOVD software ©2004-2024
Leiden University Medical Center
Database contents © by their respective submitters and curators